METHOD OF TREATING BREAST CANCER Russian patent published in 2011 - IPC A61N2/04 A61N5/06 A61K31/704 A61K31/196 A61K31/675 A61K31/513 A61K35/14 A61P35/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, oncology, and can be used in complex treatment of malignant breast tumours. Patient's blood is sampled from a peripheral vein in two containers, 100 ml in each; inductors of an apparatus for physical therapy are placed oppositely on each side of a connector tube of a dropper to expose simultaneously to red light of wave length 670 nm, dose 1-5 J/cm² and field density 5 mT, frequency 0.3 Hz for 3 minutes. Doxorubicin 50 mg is added to the first container, while Methotrexate 25 mg, cyclopohsphane 600 mg, 5-fluorouracil 750 mg are added to the second container; the contents of the containers is incubated for 40 minutes at temperature 37°C and introduced in the patient on the 1st and 8th days of treatment. On the 3rd, 5th, 10th, 12th and 15th days of treatment, 5-fluorouracil 500 mg mixed with autoblood and incubated as described above is introduced. In 14 days after the last introduction of mixed autoblood and chemopreparation, the therapeutic modalities are repeated in the same order, doses and processing.

EFFECT: lower toxicity of the chemopreparations and tumour extension.

2 dwg, 1 ex